Company / Income Tax
Amneal Pharmaceuticals, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$11.3M
FY2025
5-year range
$6.7M / $383.3M
FY2021-FY2025
Trend
-40.2%
vs FY2024
Sector context
#45 of 204
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s income tax of $11M is higher than 78% of companies in the Health Care sector (FY2025). Income Tax has fluctuated over the past 10 years, ranging from -$1M in FY2020 to $383M in FY2021.
Based on SEC 10-K filings.
$11M in FY2025 with a 3-year CAGR of +19.2%. Top quartile in the Health Care sector.
Remained stable around $11M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +19.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 204This company $11.3M Sector average $118.7M
▼
-90.5% below sector average
Key checks
Key Insights
- 3-year CAGR of +19.2%, indicating consistent growth.
- In FY2025, income tax decreased 40.2% year-over-year.
- Ranks #45 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.3M | -40.2% |
| FY2024 | $18.9M | +68.5% |
| FY2023 | $11.2M | +68.1% |
| FY2022 | $6.7M | -98.3% |
| FY2021 | $383.3M | +27114.2% |
| FY2020 | -$1.4M | -171.0% |
| FY2019 | $2.0M | -63.0% |
| FY2018 | $5.4M | +170.0% |
| FY2017 | $2.0M | -63.0% |
| FY2016 | $5.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026